Therefore, HSPB6 serves a critical function not only in regulating EMT but also in suppressing the PI3K/AKT/mTOR signaling pathway, further underscores its potential as a therapeutic target in the treatment of bladder cancer. This evidence concerns the gene MTOR and urinary bladder carcinoma.